Skip to main content
Theratechnologies Inc. logo

Theratechnologies Inc. — Investor Relations & Filings

Ticker · THTX ISIN · CA88338H1001 LEI · 5493003Q78Q8VKGF1459 US Manufacturing
Filings indexed 282 across all filing types
Latest filing 2013-01-28 Major Shareholding Noti…
Country CA Canada
Listing US THTX

About Theratechnologies Inc.

https://www.theratech.com/

Theratechnologies Inc. is a biopharmaceutical company focused on developing and commercializing specialized therapies for unmet medical needs, primarily for people living with HIV. The company's main commercial products are Trogarzo® (ibalizumab-uiyk), an antiretroviral therapy, and EGRIFTA SV®/WR™ (tesamorelin), a treatment for the reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. Its research and development pipeline is also centered on advancing treatments within the HIV field. In September 2025, the company completed its acquisition by Future Pak.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2013
Major Shareholding Notification
2013-01-28 English
FORM 25
Delisting Announcement
2013-01-28 English
FORM 6-K
Regulatory Filings
2013-01-14 English
Regulatory Filings 2012
Regulatory Filings
2012-12-10 English
Regulatory Filings 2012
Regulatory Filings
2012-12-05 English
FORM 6-K
Regulatory Filings
2012-11-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.